Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial.

MLA

Okita, Kiwamu, et al. “Survey of Survival among Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Peretinoin, an Acyclic Retinoid, after the Completion of a Randomized, Placebo-Controlled Trial.” Journal of Gastroenterology, vol. 50, no. 6, June 2015, pp. 667–74. EBSCOhost, https://doi.org/10.1007/s00535-014-0996-1.

APA

Okita, K., Izumi, N., Ikeda, K., Osaki, Y., Numata, K., Ikeda, M., Kokudo, N., Imanaka, K., Nishiguchi, S., Kondo, S., Nishigaki, Y., Shiomi, S., Ueshima, K., Isoda, N., Karino, Y., Kudo, M., Tanaka, K., Kaneko, S., Moriwaki, H., … Kumada, H. (2015). Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial. Journal of Gastroenterology, 50(6), 667–674. https://doi.org/10.1007/s00535-014-0996-1

Chicago

Okita, Kiwamu, Namiki Izumi, Kenji Ikeda, Yukio Osaki, Kazushi Numata, Masafumi Ikeda, Norihiro Kokudo, et al. 2015. “Survey of Survival among Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Peretinoin, an Acyclic Retinoid, after the Completion of a Randomized, Placebo-Controlled Trial.” Journal of Gastroenterology 50 (6): 667–74. doi:10.1007/s00535-014-0996-1.